HCPCS Code Descriptor:
Injection, mirvetuximab soravtansine-gynx, 1 mg
Route of Administration:
ELAHERE is a Oncology drug manufactured by Immunogen, Inc. and administered via the Intravenous route of administration. The J Code: J9063 is aligned to the drug ELAHERE.
ELAHERE is a cancer medication under the class of medications known as antineoplastics monoclonal antibody. It works by slowing down and killing the cancer cells. ELAHERE can be used to treat certain types of ovarian cancer, fallopian tube cancer, and peritoneal cancer. This drug is manufactured by Immunogen and is aligned to the HCPCS code J9063.